HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 205 filers reported holding HORIZON PHARMA PLC in Q4 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $826,000 | -97.7% | 69,606 | -97.1% | 0.05% | -97.2% |
| Q1 2017 | $35,611,000 | +1.0% | 2,409,396 | +10.6% | 1.78% | +9.6% |
| Q4 2016 | $35,248,000 | -6.9% | 2,178,491 | +4.4% | 1.62% | -11.0% |
| Q3 2016 | $37,849,000 | +5.0% | 2,087,636 | -4.6% | 1.82% | +4.1% |
| Q2 2016 | $36,036,000 | +5.1% | 2,187,994 | +5.8% | 1.75% | +10.5% |
| Q1 2016 | $34,278,000 | +0.6% | 2,068,654 | +31.6% | 1.58% | +11.8% |
| Q4 2015 | $34,061,000 | +13.8% | 1,571,794 | +4.1% | 1.42% | +15.5% |
| Q3 2015 | $29,935,000 | -46.8% | 1,510,340 | -6.7% | 1.23% | -40.1% |
| Q2 2015 | $56,247,000 | +38.6% | 1,619,074 | +3.6% | 2.05% | +32.3% |
| Q1 2015 | $40,589,000 | +87.4% | 1,562,904 | -7.0% | 1.55% | +75.4% |
| Q4 2014 | $21,656,000 | +106.9% | 1,680,044 | +97.1% | 0.88% | +102.8% |
| Q3 2014 | $10,469,000 | – | 852,530 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |